Sonoma Biotherapeutics
Lee Shaffer is an Associate Scientist in the Protein and Cellular Engineering group at Sonoma Bio. Before joining, he worked at Adaptive Biotechnologies in their Cellular Research and Innovation group generating antigen-specific T-cell lineages, profiling them, and pairing their TCR chains.
Shaffer received his BS in Molecular Biology from Pacific Lutheran University and worked at the University of Washington following graduation. This lab looked to understand the connection between hypothalamic inflammation and how it impacted the onset of diet-induced obesity in mice.
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.